<?xml version="1.0" encoding="UTF-8"?>
<p id="Par76">One of the most promising leads on a COVID-19 vaccine is mRNA-1273. This vaccine, developed by 
 <italic>Moderna Therapeutics</italic>, is being developed with extreme urgency, skipping straight into human trials before it was even tested in animals. This method of vaccination uses a fragment of a pathogen, typically a surface protein, to trigger an immune response, teaching the bodyâ€™s immune system how to fight off the disease without actually introducing live pathogens.
</p>
